Definium Therapeutics, Inc. - Common Shares (DFTX) SEC filings
DFTX SEC filings moved a median of -0.35% by the close. DFTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DFTX overview →
19 measured DFTX SEC filing events.
Where these DFTX SEC filings landedvs 19 measured DFTX SEC filing reactions
| Middle 50% of DFTX SEC filing reactions | -3.54% to +1.78% |
|---|---|
| Median reaction (to close) | -0.35% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 DFTX SEC filing events with a measured close landed between -3.54% and +1.78%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Definium Therapeutics, For: Sep 14 | SEC filing · Form 8-K | -3.36% | -7.47% | |
| Form 8-K Definium Therapeutics, For: Sep 08 | SEC filing · Form 8-K | +0.03% | +0.60% | |
| Form 8-K Definium Therapeutics, For: Aug 12 | SEC filing · Form 8-K | -3.14% | -8.98% | |
| Form 10-Q Definium Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.46% | -0.35% | |
| Form 8-K Definium Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +2.46% | -0.35% | |
| Form 8-K Definium Therapeutics, For: Jun 22 | SEC filing · Form 8-K | +4.07% | +6.67% | |
| Form 8-K Definium Therapeutics, For: Jun 22 | SEC filing · Form 8-K | -0.21% | -4.78% | |
| Form S-8 Definium Therapeutics, | SEC filing · Form S-8 | +0.08% | +1.20% | |
| Form 8-K Definium Therapeutics, For: Jun 11 | SEC filing · Form 8-K | -0.32% | -4.04% | |
| Form 8-K Definium Therapeutics, For: May 19 | SEC filing · Form 8-K | -1.79% | -1.72% | |
| Form 8-K Definium Therapeutics, For: May 12 | SEC filing · Form 8-K | -1.12% | -1.17% | |
| Form 10-Q Definium Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.18% | -3.54% | |
| Form 8-K Definium Therapeutics, For: May 07 | SEC filing · Form 8-K | -4.18% | -3.54% | |
| Form DEF 14A Definium Therapeutics, For: Jun 11 | SEC filing · Form DEF | +1.54% | +2.11% | |
| Form DEFA14A Definium Therapeutics, | SEC filing · Form DEFA14A | +1.54% | +2.11% | |
| Form 8-K Definium Therapeutics, For: Apr 22 | SEC filing · Form 8-K | -0.35% | +1.44% | |
| Form 10-K Definium Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.62% | +2.59% | |
| Form 8-K Definium Therapeutics, For: Feb 26 | SEC filing · Form 8-K | +3.62% | +2.59% | |
| Form 8-K Definium Therapeutics, For: Jan 28 | SEC filing · Form 8-K | -0.61% | +0.47% |
Keep exploring
More DFTX: earnings → · analyst actions → · DFTX overview →